Shigeto Negi
Eisai
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shigeto Negi.
Tetrahedron | 2001
Taichi Abe; Toyokazu Haga; Shigeto Negi; Yukio Morita; Keizou Takayanagi; Kimio Hamamura
Abstract The modification of sodium bis(2-methoxyethoxy)aluminum hydride (SMEAH) with pyrrolidine provided a highly selective reducing agent to transform N -benzyl-4-ethoxycarbonylpiperidine into N -benzyl-4-formylpiperidine 1 under mild conditions. However, this simple modification led to a significant amount of N -benzyl-4-(pyrrolidin-1-ylmethyl)piperidine 4 due to overreduction of an intermediate. Our extensive research revealed that an alkaline base such as potassium tert -butoxide could suppress the formation of the by-product to give the desired aldehyde, enabling us to establish a viable synthetic process for a key intermediate of donepezil hydrochloride. The potential applications of this reagent are also described.
Synthetic Communications | 1980
Yoshimasa Machida; Seiichiro Nomoto; Shigeto Negi; Hironori Ikuta; Isao Saito
Abstract 4-Oxo-4-H-1-benzopyran-3-carboxylic acids and their derivatives (esters and amides), 2, are known to possess interesting pharmacological activities.1 As part of our synthetic studies of biologically active compounds, we needed to prepare a variety of 2 (carboxylic acids, esters, amides, etc.). An elegant method for the preparation of 4-oxo-4H-1-benzopyran-3-carboxaldehydes, 1, was reported independently by Nohara et al. 2 and Harnish.3 However, despite a rather extensive effort by Nohara et al., the oxidation of 1 to 2 (Y=OH) has not been realized in good yield; thus the yields by Jones oxidation, the best reported method, ranged only from 9.5 to 39%.4
Synthetic Communications | 1997
Akihiko Tsuruoka; Shigeto Negi; Manabu Yanagisawa; Kazumasa Nara
Abstract Trisubstituted oxirane 1 was regiospecifically opened with LiCN in situ prepared from acetone cyanohydrin and LiH to provide the corresponding β-hydroxy nitrile 2 in satisfactory yield, enabling us to manufacture a key intermediate for a new antifungal agent on a multi-kg scale. Some applications of this method to the ring opening of other oxiranes and nucleophilic substitution are also described.
Journal of Labelled Compounds and Radiopharmaceuticals | 1996
Shigeto Negi; Yuki Komatsu; Akihiko Tsuruoka; Yuji Uemura
The new broad-spectrum oral antibacterial agent E1101, has been labelled in the C-2 position of the aminothiazole ring using [ 14 C]thiourea. The cephalosporin analog was synthesized in 5 steps and is suitable for metabolism and disposition studies.
Archive | 2000
Hiroshi Akamatsu; Osamu Asano; Toyokazu Haga; Hitoshi Harada; Kenji Hayashi; Tatsuo Horizoe; Takashi Inoue; Tsutomu Kawata; Seiichi Kobayashi; Hiroe Minami; Manabu Murakami; Junsaku Nagaoka; Toshihiko Naito; Shigeto Negi; Kaya Ohashi; Naoki Ozeki; Toshikazu Shimizu; Naoyuki Shimomura; Isao Tanaka; Nobuhisa Watanabe; Nobuyuki Yasuda; Seiji Yoshikawa
Synthesis | 1996
Shigeto Negi; Masayuki Matsukura; Masanori Mizuno; Kazutoshi Miyake; Norio Minami
Archive | 1990
Takashi Kamiya; Toshihiko Naito; Shigeto Negi; Yuuki Komatu; Yasunobu Kai; Takaharu Nakamura; Isao Sugiyama; Yoshimasa Machida; Seiichiro Nomoto; Kyosuke Kitoh; Kanemasa Katsu; Hiroshi Yamauchi
Archive | 1989
Takashi Kamiya; Toshihiko Naito; Yuuki Komatu; Yasunobu Kai; Takaharu Nakamura; Manabu Sasho; Shigeto Negi; Isao Sugiyama; Kanemasa Katsu; Hiroshi Yamauchi
Archive | 2000
Osamu Asano; Hitoshi Harada; Seiji Yoshikawa; Nobuhisa Watanabe; Takashi Inoue; Tatsuo Horizoe; Nobuyuki Yasuda; Kaya Ohashi; Hiroe Minami; Junsaku Nagaoka; Manabu Murakami; Seiichi Kobayashi; Isao Tanaka; Tsutomu Kawata; Naoyuki Shimomura; Hiroshi Akamatsu; Naoki Ozeki; Toshikazu Shimizu; Kenji Hayashi; Toyokazu Haga; Shigeto Negi; Toshihiko Naito
Archive | 1987
Takashi Kamiya; Toshihiko Naito; Shigeto Negi; Yuuki Komatu; Yasunobu Kai; Takaharu Nakamura; Isao Sugiyama; Yoshimasa Machida; Seiichiro Nomoto; Kyosuke Kitoh; Kanemasa Katsu; Hiroshi Yamauchi